The 5-HT1A receptor agonist MKC-242 increases the exploratory activity of mice in the elevated plus-maze

European Journal of Pharmacology

Volumn 458, Issue 1-2, 2003, Pages 141-144

  Sakaue, Masaki ^a   Ago, Yukio ^a   Sowa, Chikako ^a   Koyama, Yutaka ^a   Baba, Akemichi ^a   Matsuda, Toshio ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

(Mouse); 5 HT1A receptor; MKC 242; Plus maze test

Indexed keywords

AUTORECEPTOR; DIAZEPAM; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; OSEMOZOTAN; SEROTONIN 1A AGONIST; 1,3 DIOXOLANE DERIVATIVE; ANXIOLYTIC AGENT; DIOXANE DERIVATIVE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN 1 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; EXPLORATORY BEHAVIOR; MAZE TEST; MOUSE; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; ANIMAL; ANIMAL BEHAVIOR; DOSE RESPONSE; MALE; MOTOR ACTIVITY; PHYSIOLOGY;

ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; DIAZEPAM; DIOXANES; DIOXOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; MALE; MAZE LEARNING; MICE; MOTOR ACTIVITY; PIPERAZINES; PYRIDINES; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 1842831564     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02786-3     Document Type: Article

References (17)

1. Abe M., Tabata R., Saito K., Matsuda T., Baba A., Egawa M. Novel benzodioxan derivative, 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole HCl (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models. J. Pharmacol. Exp. Ther. 278:1996;898-905.
2. Cole J.C., Rodgers R.J. Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. Psychopharmacology. 114:1994;288-296.
3. 1A antagonist, WAY100635. Psychopharmacology. 132:1997;35-43.
4. 1A receptor antagonism. Neuropharmacology. 38:1999;1153-1163.
5. 1A receptor agonists: recent developments and controversial issues. Psychopharmacology. 121:1995;1-16.
6. 1A receptor modulation of anxiety in two ethological animal tests. J. Neurosci. 16:1996;4810-4815.
7. 1A receptors on central noradrenergic activity: microdialysis studies using (±)-MDL 73005EF and its enantiomers. Neuropharmacology. 38:1999;299-306.
8. 1A agonists with potential anxiolytic properties. J. Pharmcol. Exp. Ther. 246:1988;745-752.
9. Handley S.L., McBlane J.W. 5HT drugs in animal models of anxiety. Psychopharmacology. 112:1993;13-20.
10. Hoggs S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 54:1996;21-30.
11. Lister R.G. The use of the plus-maze to measure anxiety in the mouse. Psychopharmacology. 92:1987;180-185.
12. 1A receptors. Jpn. J. Pharmacol. 69:1995;357-366.
13. Moser P.C. An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone. Psychopharmacology. 99:1989;48-53.
14. 1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. Neurosci. Lett. 219:1996;123-126.
15. 1A receptor activation increases in vivo dopamine release in rat prefrontal cortex. Br. J. Pharmacol. 129:2000;1028-1034.
16. Setem J., Pinheiro A.P., Motta V.A., Morato S., Cruz A.P.M. Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze. Pharmacol. Biochem. Behav. 62:1999;515-521.
17. 1A receptor agonist, facilitates cortical acetylcholine release by a mechanism different from that of 8-OH-DPAT in awake rats. Neuropharmacology. 36:1997;1733-1739.